Citius Oncology Ownership | Who Owns Citius Oncology?

Citius Oncology Ownership Summary

Citius Oncology is owned by 14.24% institutional investors, 79.64% insiders, and 6.12% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 0% of CTOR shares. Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund, with 0.40% of its assets in Citius Oncology shares.

CTOR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Citius Oncology	14.24%	79.64%	6.12%
Sector	Healthcare Stocks	35.56%	12.08%	52.36%
Industry	Drug Manufacturers - General Stocks	45.56%	5.78%	48.65%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Blackrock funding, inc. /de	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	-	-	-47.45K

Top Sellers

Holder	Shares	% Assets	Change
Blackrock funding, inc. /de	-	-	-47.45K

Sold Out

Holder	Change
Blackrock funding, inc. /de	-47.45K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	13	-23.53%	14,247,638	107.66%	14	23.15%	9	-10.00%	1	-75.00%
Dec 31, 2025	17	6.25%	6,861,177	-17.90%	7	6.03%	10	-23.08%	4	100.00%
Sep 30, 2025	16	128.57%	8,357,159	3573.61%	11	11285.28%	13	160.00%	2	100.00%
Jun 30, 2025	7	-	227,492	94.43%	-	1189.17%	5	66.67%	1	-
Mar 31, 2025	7	-36.36%	117,007	-41.75%	-	207.44%	3	-57.14%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Morn Total Stk Mkt Idx Investor	370.10K	0.40%	-
Vanguard Total Stock Mkt Idx Inv	370.10K	0.40%	-
Vanguard Institutional Extnd Mkt Idx Tr	176.22K	0.19%	-
Fidelity Extended Market Index	98.20K	0.11%	-14.54K
Fidelity Nasdaq Composite Index	54.73K	0.06%	-2.57K
iShares Micro-Cap ETF	44.96K	0.05%	-
Spartan Extended Market Index Pool F	29.84K	0.03%	163.00
Fidelity Total Market Index	26.29K	0.03%	-
Fidelity Series Total Market Index	23.39K	0.03%	-
Northern Trust Extended Eq Market Idx	23.37K	0.03%	-

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-

CTOR Ownership FAQ

Who Owns Citius Oncology?

Citius Oncology shareholders are primarily institutional investors at 14.24%, followed by 79.64% insiders and 6.12% retail investors. The average institutional ownership in Citius Oncology's industry, Drug Manufacturers - General Stocks, is 45.56%, which Citius Oncology falls below.

Does Blackrock own Citius Oncology?

BlackRock is not among the top 10 institutional shareholders of Citius Oncology.

Who is Citius Oncology’s biggest shareholder by percentage of total assets invested?

Blackrock funding, inc. /de is Citius Oncology’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Citius Oncology shares, valued at 0$.

Who is the top mutual fund holder of Citius Oncology shares?

Vanguard Morn Total Stk Mkt Idx Investor is the top mutual fund holder of Citius Oncology shares, with 0.40% of its total shares outstanding invested in 370.1K Citius Oncology shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools